Illustration: Sarah Grillo/Axios

Slowdowns in mail delivery could have serious consequences for the millions of Americans who get prescription drugs — in some cases, lifesaving treatments — through the mail.

Why it matters: Treatments for cancer, multiple sclerosis, rheumatoid arthritis and other complex diseases increasingly are sent in the mail. And the coronavirus pandemic has spurred more people to get their routine prescriptions mailed to their homes, as a safer alternative to visiting a pharmacy.

Driving the news: Postmaster General Louis DeJoy said Tuesday that he would suspend the controversial operational changes that Democrats had widely criticized as a threat to timely mail-in voting this November.

  • House Speaker Nancy Pelosi said Democrats would still continue their oversight of the postal service — which has included questions for the pharmacy industry about possible delays, as well as concerns about delays for VA patients.

By the numbers: Americans received 313 million adjusted prescriptions through the mail in 2019, often for common, generic medications that treat things like high cholesterol and high blood pressure.

  • Even though that's only 5% of all prescriptions, mail orders represent roughly a quarter of all drug spending, according to health data firm IQVIA, thanks to the growing mail-order business for expensive pills that treat complex diseases.

Consequently, the U.S. Postal Service has become a critical backbone of the country's medication infrastructure.

Where it stands: Even before Tuesday's announcement, the disruption to prescription deliveries seems to have been minimal.

  • In the latest Axios-Ipsos Coronavirus Index, just 5% of respondents said they had been expecting a drug delivery in the past week but either hadn't gotten it or had gotten it late. (14% were expecting a delivery and got it in time.)
  • But anecdotally, for the people who are experiencing delays, the worries are real.

The bottom line: "My patients who rely on their insulin, or their inhalers, or any other type of medication can't wait weeks to see whether or not their prescription will be delivered," Jacqueline Fincher, the president of the American College of Physicians, said in a statement.

Go deeper

Christopher Wray: FBI has not seen evidence of national voter fraud effort by mail

FBI Director Christopher Wray responded to a question on the security of mail-in voting to the Senate Homeland Security Committee on Thursday by saying that the agency has "not seen, historically, any kind of coordinated national voter fraud effort in a major election, whether it's by mail or otherwise."

Why it matters: President Trump has ramped up his claims, without evidence, that widespread mail-in voting would rig the 2020 election against him. On Wednesday, after declining to say whether he would commit to a peaceful transition of power if he loses the election to Joe Biden, Trump said that "the ballots are out of control."

Trump unveils health care vision, but offers little detail

President Trump in Charlotte, North Carolina. Photo: Brian Blanco/Getty Images

President Trump outlined his ambitions for health care policy in a North Carolina speech Thursday, promising "the highest standard of care anywhere in the world," before signing an executive order guaranteeing protections for pre-existing conditions and then pledging to ban surprise medical bills.

Reality check: The only reason that pre-existing conditions protections, which are guaranteed under the Affordable Care Act, are at risk is because a Trump-backed lawsuit against the law is pending before the Supreme Court. Trump's executive order offers few details, and executive orders in and of themselves don't change policy. The order "simply declares it's national policy to protect coverage of people with preexisting conditions," Politico writes.

Bob Woodward: "I was not going to hide" my opinion on Trump

Bob Woodward didn't want to join Senate Republicans in privately condemning President Trump but declining to do so publicly, he told Jonathan Swan in an interview for "Axios on HBO."

Why it matters: Woodward has covered 9 presidents, but Trump is the first that Woodward explicitly described as "the wrong man for the job."